Breaking News Instant updates and real-time market news.

BCYC

Bicycle Therapeutics

$11.50

-0.35 (-2.95%)

14:56
09/29/19
09/29
14:56
09/29/19
14:56

Bicycle Therapeutics presents data from Phase I/IIa trial evaluating BT1718

Bicycle Therapeutics announced the presentation of updated data from a Phase I/IIa trial conducted in collaboration with Cancer Research UK and evaluating BT1718 in an unselected group of patients with advanced solid tumors. Patients in the Phase I dose escalation were assessed for anti-tumor activity, safety and pharmacokinetics up to the data cutoff of August 7, 2019. Based on data from patients in cohorts across dose levels tested, many of which are below the predicted therapeutic range, 13 of 24 evaluable patients had stable disease at the eight-week timepoint, including a patient who experienced a 45% reduction in a target lesion. With once-weekly dosing, which is the expected schedule for the Phase IIa portion of the study, BT1718 has appeared tolerable, with manageable adverse events. The Phase I once-weekly dose escalation portion of the trial is ongoing, with dosing at levels equivalent to those associated with preclinical responses. Evaluation of pharmacokinetics demonstrated that BT1718 area under the curve was approximately dose proportional over the range 0.6-25 mg/m2, and cycle 2 values were consistent with cycle 1. Mean plasma clearance was 33.6 L/h, with mean volume of distribution of 12.5 L, resulting in a terminal half-life of 0.2 to 0.5 hours. Two tumor biopsies were obtained from patients dosed at levels above 15 mg/m2 and analysis showed delivery of DM1 to the tumor consistent with preclinical models. These findings suggest rapid tumor penetration by BT1718. Further plasma and tumor DM1 analysis is ongoing to assess the extent of DM1 retention. The Phase I/IIa study of BT1718 is being sponsored by Cancer Research UK. The primary objectives of the Phase I dose escalation portion of the trial are to select the recommended Phase II dose by establishing the maximum tolerated dose and maximum administered dose, and to assess the safety and toxicity profile of BT1718 in patients with advanced solid tumors. Following selection of the once-weekly RP2D, the Phase IIa portion of the study, consisting of up to four cohorts in selected indications in which MT1-MMP is expressed, will be initiated.

BCYC Bicycle Therapeutics
$11.50

-0.35 (-2.95%)

06/17/19
ADAM
06/17/19
INITIATION
Target $22
ADAM
Buy
Bicycle Therapeutics initiated with a Buy at Canaccord
Canaccord analyst Arlinda Lee initiated Bicycle Therapeutics with a Buy rating citing its proprietary phage display screening platform which directs the evolution of bicyclic peptides to rapidly and empirically generate optimized novel drug candidates. Lee has a $22 price target on Bicycle Therapeutics shares.
06/17/19
JEFF
06/17/19
INITIATION
Target $27
JEFF
Buy
Bicycle Therapeutics initiated with a Buy at Jefferies
Jefferies analyst Biren Amin started Bicycle Therapeutics with a Buy rating and $27 price target. While early in development, the company may offer a differentiated approach, and its lead program BT1718 should provide first clinical data in the second half of 2019 in multiple MT1-MMP-positive solid tumors, Amin tells investors in a research note.
09/11/19
GSCO
09/11/19
UPGRADE
Target $14
GSCO
Buy
Bicycle Therapeutics upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Graig Suvannavejh upgraded Bicycle Therapeutics to Buy from Neutral with a $14 price target.
09/11/19
GSCO
09/11/19
UPGRADE
Target $14
GSCO
Buy
Goldman upgrades Bicycle Therapeutics to Buy on 'compelling' entry point
Goldman Sachs analyst Graig Suvannavejh upgraded Bicycle Therapeutics to Buy from Neutral with a $14 price target. The stock's 50% decline since the May initial public offering "appears unjustified," Suvannavejh tells investors in a research note. The analyst see no material developments/news from the company to account from the move and says that if anything, positive top-line Phase 1 data was reported in Q2 for a partnered ophthalmology candidate, THR-149. As such, he finds Bicycle's risk/reward as positive and believes the shares now offer a "compelling price point."

TODAY'S FREE FLY STORIES

PM

Philip Morris

$79.12

0.8 (1.02%)

, HON

Honeywell

$163.86

0.2 (0.12%)

20:25
10/16/19
10/16
20:25
10/16/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$79.12

0.8 (1.02%)

HON

Honeywell

$163.86

0.2 (0.12%)

UNP

Union Pacific

$163.31

0.11 (0.07%)

MS

Morgan Stanley

$42.82

0.28 (0.66%)

BBT

BB&T

$53.00

0.25 (0.47%)

STI

SunTrust

$68.28

0.23 (0.34%)

PPG

PPG

$118.89

0.665 (0.56%)

MTB

M&T Bank

$159.14

0.27 (0.17%)

KEY

KeyCorp

$17.70

-0.08 (-0.45%)

GPC

Genuine Parts

$97.72

-0.22 (-0.22%)

DOV

Dover

$95.71

-0.24 (-0.25%)

TXT

Textron

$50.52

-0.15 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 04

    Nov

  • 08

    Nov

  • 10

    Nov

  • 11

    Nov

  • 12

    Nov

GLD

SPDR Gold Shares

$140.39

0.81 (0.58%)

20:11
10/16/19
10/16
20:11
10/16/19
20:11
Hot Stocks
SPDR Gold Shares holdings fall to 918.19MT from 919.66MT »

This is the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$3.60

-0.15 (-4.00%)

19:20
10/16/19
10/16
19:20
10/16/19
19:20
Hot Stocks
Aurora Cannabis to roll out vapes, concentrates, edibles in Canada in December »

On the one-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TEVA

Teva

$6.94

-0.02 (-0.29%)

19:20
10/16/19
10/16
19:20
10/16/19
19:20
Upgrade
Teva rating change at Gabelli »

Teva upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CAAP

Corporacion America Airport

$4.39

-0.09 (-2.01%)

19:14
10/16/19
10/16
19:14
10/16/19
19:14
Hot Stocks
Corporacion America Airport reports September passenger traffic up 1.2% »

Corporacion America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$36.65

0.38 (1.05%)

19:10
10/16/19
10/16
19:10
10/16/19
19:10
Periodicals
Tentative GM-UAW deal does not include reopening of Lordstown plant, NYP says »

A tentative agreement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

LLNW

Limelight Networks

$3.10

-0.08 (-2.52%)

, NFLX

Netflix

$286.83

2.59 (0.91%)

18:55
10/16/19
10/16
18:55
10/16/19
18:55
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

LLNW

Limelight Networks

$3.10

-0.08 (-2.52%)

NFLX

Netflix

$286.83

2.59 (0.91%)

TCBI

Texas Capital

$54.33

-0.15 (-0.28%)

CSX

CSX

$68.99

-0.18 (-0.26%)

AA

Alcoa

$19.17

-0.28 (-1.44%)

CCI

Crown Castle

$134.76

0.11 (0.08%)

RGLS

Regulus

$0.72

0.0501 (7.54%)

IBM

IBM

$142.04

-0.94 (-0.66%)

URI

United Rentals

$121.73

1.02 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 27

    Oct

  • 29

    Oct

  • 13

    Nov

NFLX

Netflix

$286.83

2.59 (0.91%)

18:37
10/16/19
10/16
18:37
10/16/19
18:37
Hot Stocks
Netflix says shares viewing data with producers each week »

Says shares viewing data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

BRBR

BellRing Brands

$0.00

(0.00%)

18:34
10/16/19
10/16
18:34
10/16/19
18:34
Syndicate
BellRing Brands 34.29M share IPO priced at $14.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GSBC

Great Southern Bancorp

$57.28

-0.03 (-0.05%)

18:32
10/16/19
10/16
18:32
10/16/19
18:32
Earnings
Great Southern Bancorp reports Q3 preliminary EPS $1.38, consensus $1.23 »

Reports Q3 NII $45.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CRM

Salesforce

$146.96

-5.89 (-3.85%)

, FB

Facebook

$189.62

0.81 (0.43%)

18:26
10/16/19
10/16
18:26
10/16/19
18:26
Hot Stocks
Salesforce CEO: Steve Jobs had a huge impact on my life »

In an interview on…

CRM

Salesforce

$146.96

-5.89 (-3.85%)

FB

Facebook

$189.62

0.81 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 16

    Dec

NFLX

Netflix

$286.83

2.59 (0.91%)

18:19
10/16/19
10/16
18:19
10/16/19
18:19
Hot Stocks
Netflix to test mobile only plans in other markets »

Says will test mobile…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

MESO

Mesoblast

$6.04

-0.03 (-0.49%)

, LZAGY

Lonza

$0.00

(0.00%)

18:18
10/16/19
10/16
18:18
10/16/19
18:18
Hot Stocks
Mesoblast, Lonza enter into manufacture agreement of remestemcel-L in U.S. »

Mesoblast (MESO) and…

MESO

Mesoblast

$6.04

-0.03 (-0.49%)

LZAGY

Lonza

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$286.83

2.59 (0.91%)

18:12
10/16/19
10/16
18:12
10/16/19
18:12
Hot Stocks
Neflix says price increase responsible for U.S. shortfall »

Says price increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:06
10/16/19
10/16
18:06
10/16/19
18:06
Hot Stocks
Steel Dynamics CEO says steel pricing environment 'challenging' »

"Our third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

18:06
10/16/19
10/16
18:06
10/16/19
18:06
Hot Stocks
Netflix says price increases 'hugely' revenue positive »

Says Q3 was a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

DLPN

Dolphin Entertainment

$0.79

(0.00%)

18:05
10/16/19
10/16
18:05
10/16/19
18:05
Syndicate
Dolphin Entertainment offers to sell common stock, no amount given »

Maxim Group LLC is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:03
10/16/19
10/16
18:03
10/16/19
18:03
Hot Stocks
Steel Dynamics says 'constructive' on 2020 North American steel market dynamics »

"Based on domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

STLD

Steel Dynamics

$28.83

-1.29 (-4.28%)

18:01
10/16/19
10/16
18:01
10/16/19
18:01
Earnings
Steel Dynamics reports Q3 EPS 69c, consensus 70c »

Reports Q3 revenue $2.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ISTR

Investar Holding

$23.98

0.08 (0.33%)

18:01
10/16/19
10/16
18:01
10/16/19
18:01
Hot Stocks
Investar Holding gains regulatory, holder approvals for Bank of York acquisition »

Investar Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSX

CSX

$68.99

-0.18 (-0.26%)

17:57
10/16/19
10/16
17:57
10/16/19
17:57
Hot Stocks
CSX reverses in after-hours, trading up over 4% »

Shares of CSX are now up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 13

    Nov

EGO

Eldorado Gold

$7.40

0.175 (2.42%)

17:50
10/16/19
10/16
17:50
10/16/19
17:50
Hot Stocks
Eldorado Gold reports Q3 preliminary gold production of 101,596 oz. »

Eldorado Gold reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

BHP

BHP Group

$48.17

-0.51 (-1.05%)

17:38
10/16/19
10/16
17:38
10/16/19
17:38
Hot Stocks
BHP Group backs FY20 iron ore output view of 242-253 MT »

Backs FY20 petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

PEGI

Pattern Energy

$26.14

-0.26 (-0.98%)

17:37
10/16/19
10/16
17:37
10/16/19
17:37
Downgrade
Pattern Energy rating change at Goldman Sachs »

Pattern Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

BHP

BHP Group

$48.17

-0.51 (-1.05%)

17:35
10/16/19
10/16
17:35
10/16/19
17:35
Hot Stocks
BHP Group reports Q1 iron ore output 61MT, down 1% from last year »

Reports Q1 petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.